AVNS - Avanos Medical Inc
(NaN%)
Sell
Weak Growth●Earnings/Profit is Negative
22%
based on last 5 year data.
Income Statement is WEAK
Revenue Growth is 1.34%
Operating Income is Negative
Net Income is Negative
Earnings Per Share (EPS) is Negative
Net Margin is -55.8%
Balance Sheet is MODERATE
Current Asset to Current Liability Ratio is 2.57
Debt Ratio is 0.24
Current Debt to Net Income Ratio is 1.42
Total Debt to Total Assets Ratio is 0.1
Cash Flow is MODERATE
Cash from Operations Growth is 330.77%
Capital Expenditure not available
Net Increase in Cash is Positive
Long Term Score Trend is NEGATIVE
Investment Risk is High
based on last 4 quarter data.
Better viewed in landscape mode.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
Avanos Medical Inc (AVNS) - https://avanos.com/
avanos is a medical device company focused on delivering clinically superior breakthrough solutions that will help patients get back to the things that matter.headquartered in alpharetta, georgia, avanos is committed to creating the next generation of innovative healthcare solutions which will address our most important healthcare needs, such as reducing the use of opioids while helping patients move from surgery to recovery.avanos develops, manufactures and markets its recognized brands in more than 90 countries.Exchange - NEW YORK STOCK EXCHANGE INC.
Industry - Surgical Appliance and Supplies Manufacturing
Sector - Manufacturing
CEO - Joseph Woody
Employees - 1,357
Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2025 and future.
Know the Stock © 2025 and future.